drugset / Trial / NCT03069963

PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects

NCT03069963 ↗

Phase 1 Completed 24 enrolled Sanofi
RandomizedCrossoverOpen-labelBasic science

Summary

Primary Objective: Pharmacodynamics: assessment by pH metry of the change in gastric pH (antacid activity) of Z0063, in comparison to the effect of Gaviscon Double Action Tablets, in healthy adult subjects. Secondary Objective: Safety: assessment of the clinical safety of Z0063, and Gaviscon Double Action Tablets, in healthy adult subjects.

Timeline

Start
2017-02-24
Primary completion
2017-04-23
Completion
2017-04-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Gaviscon Unknown — Oral
Subject Z0063 Unknown — Oral